{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:27:21Z","timestamp":1737782841656,"version":"3.33.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1007\/bf02788754","type":"journal-article","created":{"date-parts":[[2007,12,22]],"date-time":"2007-12-22T10:33:39Z","timestamp":1198319619000},"page":"117-123","source":"Crossref","is-referenced-by-count":2,"title":["Primary biliary cirrhosis"],"prefix":"10.1007","volume":"18","author":[{"given":"Yaron","family":"Bar-Dayan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02788754_CR1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","volume":"350","author":"J Neuberger","year":"1997","unstructured":"Neuberger J: Primary biliary cirrhosis. Lancet 1997;350:875\u2013879.","journal-title":"Lancet"},{"key":"BF02788754_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJM198702263160907","volume":"316","author":"MM Kaplan","year":"1987","unstructured":"Kaplan MM: Primary biliary cirrhosis. N Engl J Med 1987;316:521\u2013528.","journal-title":"N Engl J Med"},{"key":"BF02788754_CR3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","volume":"335","author":"MM Kaplan","year":"1996","unstructured":"Kaplan MM: Primary biliary cirrhosis. N Engl J Med 1996;335: 1570\u20131578.","journal-title":"N Engl J Med"},{"key":"BF02788754_CR4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","volume":"98","author":"K Balasubramaniam","year":"1990","unstructured":"Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER, Diminished survival in asymptomatic primary biliary cirrhosis, a prospective study. Gastroenterology 1990;98:1567\u20131571.","journal-title":"Gastroenterology"},{"key":"BF02788754_CR5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","volume":"20","author":"TC Mahl","year":"1994","unstructured":"Mahl TC, Shockcor W, Boyer JL: Primary biliary cirrhosis, survival of a large cohort of symptomatic and asymptomatic patients followed for 24 yr. J Hepatol 1994;20:707\u2013713.","journal-title":"J Hepatol"},{"key":"BF02788754_CR6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","volume":"312","author":"ER Dickson","year":"1985","unstructured":"Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, McCall JT: Trial of penicillamine in primary biliary cirrhosis. N Engl J Med 1985;312:1011\u20131015.","journal-title":"N Engl J Med"},{"key":"BF02788754_CR7","first-page":"113","volume":"28","author":"Y Shoenfeld","year":"1992","unstructured":"Shoenfeld Y:Primary biliary cirrhosis and autoimmune rheumatic diseases, \u03b3 prediction and prevention. Isr J Med Sci, 1992;28:113\u2013116.","journal-title":"Isr J Med Sci"},{"key":"BF02788754_CR8","first-page":"525","volume":"143","author":"Y Shoenfeld","year":"1992","unstructured":"Shoenfeld Y: What is going to happen as far as the prediction of autoimmune disorders is concerned? Ann Med Interne 1992;143:525\u2013526.","journal-title":"Ann Med Interne"},{"key":"BF02788754_CR9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-99-4-500","volume":"99","author":"SP James","year":"1983","unstructured":"James SP, Hoofnagle JH, Strober W, Jones EA: Primary biliary cirrhosis, a model autoimmune disease. Ann Intern Med 1983;99:500\u2013512.","journal-title":"Ann Intern Med"},{"key":"BF02788754_CR10","first-page":"823","volume":"33","author":"P Rotman","year":"1997","unstructured":"Rotman P, Levi Y, Shoenfeld Y: Primary biliary cirrhosis\u2014association or overlap with other autoimmune diseases. Isr J Med Sci 1997;33:823\u2013825.","journal-title":"Isr J Med Sci"},{"key":"BF02788754_CR11","first-page":"365","volume":"57","author":"KS Culp","year":"1982","unstructured":"Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER: Autoimmune association in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365\u2013370.","journal-title":"Mayo Clin Proc"},{"key":"BF02788754_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00918181","volume":"11","author":"N Zurgil","year":"1991","unstructured":"Zurgil N, Bakimer R, Kaplan M, Youinou P, Shoenfeld Y: Antipyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. J Clin Immunol 1991;11:239\u2013245.","journal-title":"J Clin Immunol"},{"key":"BF02788754_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","volume":"1","author":"JG Walker","year":"1965","unstructured":"Walker JG, Doniach D, Roitt IM, Sherlock S: Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965;1:827\u2013830.","journal-title":"Lancet"},{"key":"BF02788754_CR14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","volume":"320","author":"J Water Van de","year":"1989","unstructured":"Van de Water J, Cooper A, Surh CD, Coppel R, Danner D, Ansari A, Dickson R, Gershwin ME: detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis. N Engl J Med 1989;320:1377\u20131380.","journal-title":"N Engl J Med"},{"key":"BF02788754_CR15","first-page":"341","volume":"36","author":"F Konikoff","year":"1989","unstructured":"Konikoff F, Isenberg DA, Barrison I, Theodor E, Shoenfeld Y: Antinuclear autoantibodies in chronic liver diseases. Hepatogastroenterology 1989;36:341\u2013345.","journal-title":"Hepatogastroenterology"},{"key":"BF02788754_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","volume":"28","author":"GH Elta","year":"1983","unstructured":"Elta GH, Sepersky RA, Goldberg MJ, Connors CM, Miller KB, Kaplan MM: Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 1983; 28:971\u2013975.","journal-title":"Dig Dis Sci"},{"key":"BF02788754_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01309512","volume":"30","author":"A Pares","year":"1985","unstructured":"Pares A, Martorell J, Caballeria J, Vives J, Bruguera M, Rodes J: Lymphocytotoxic antibodies in primary biliary cirrhosis. Dig Dis Sci 1985;30:829\u2013833.","journal-title":"Dig Dis Sci"},{"key":"BF02788754_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.0954-6820.1985.tb03256.x","volume":"217","author":"AC Sundewall","year":"1985","unstructured":"Sundewall AC, Lefvert AK, Olsson R: Antiacetylcholine receptor antibodies in primary biliary cirrhosis. Acta Med Scand 1985;217:519\u2013525.","journal-title":"Acta Med Scand"},{"key":"BF02788754_CR19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/gut.26.10.1074","volume":"26","author":"MF Bassendine","year":"1985","unstructured":"Bassendine MF, Collins JD, Stephenson J, Saunders P, James OF: Platelet associated immunoglobulins in primary biliary cirrhosis, a cause of thrombocytopenia? Gut 1985;26:1074\u20131079.","journal-title":"Gut"},{"key":"BF02788754_CR20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0016-5085(86)91129-7","volume":"90","author":"E Penner","year":"1986","unstructured":"Penner E: Demonstration of immune complexes containing the ribonucleoprotein antigen Ro in primary biliary cirrhosis. Gastroenterology 1986;90:724\u2013727.","journal-title":"Gastroenterology"},{"key":"BF02788754_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0090-1229(89)90207-9","volume":"51","author":"F Konikoff","year":"1989","unstructured":"Konikoff F, Swissa M, Shoenfeld Y: Autoantibodies to histones and their subfractions in chronic liver diseases. Clin Immunol Immunopathol 1989;51:77\u201382.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02788754_CR22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","volume":"10","author":"S Parveen","year":"1995","unstructured":"Parveen S, Morshed SA, Nishioka M: High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis, nuclear immunofluorescence patterns and ELISA reactivities. J Gastroenterol Hepatol 1995;10:438\u2013445.","journal-title":"J Gastroenterol Hepatol"},{"key":"BF02788754_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7326\/0003-4819-100-3-385","volume":"100","author":"KB Miller","year":"1984","unstructured":"Miller KB, Elta GH, Rudders RA, Kaplan MM: Lymphocyte subsets in primary biliary cirrhosis. Ann Intern Med 1984;100:385\u2013387.","journal-title":"Ann Intern Med"},{"key":"BF02788754_CR24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1172\/JCI109982","volume":"66","author":"SP James","year":"1980","unstructured":"James SP, Elson CO, Waggoner JG, Jones EA, Strober W: Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. J Clin Invest 1980;66:1305\u20131310.","journal-title":"J Clin Invest"},{"key":"BF02788754_CR25","first-page":"239","volume":"41","author":"R Moreno-Otero","year":"1994","unstructured":"Moreno-Otero R, Civeira MP, Suou T, Kanof ME, James SP, Jones EA: Reduced numbers of CD8+ T cells and B cell expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis. Hepatogastroenterology 1994; 41:239\u2013243.","journal-title":"Hepatogastroenterology"},{"key":"BF02788754_CR26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.1840160413","volume":"16","author":"JL Menendez","year":"1992","unstructured":"Menendez JL, Giron JA, Manzano L, Garrido A, Abreu L, Albillos A, Durontez A, Alvarez-Mon M: Deficient interleukin-2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis. Hepatology 1992;16:931\u2013936.","journal-title":"Hepatology"},{"key":"BF02788754_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-8278(92)90024-J","volume":"15","author":"U Spengler","year":"1992","unstructured":"Spengler U, Moller A, Jung MC, Messer G, Zachoval G, Hoffmann RM, Eisenberg J, Paumgartner G, Riethmuller G, Weiss EH: T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxins, tumor necrosis factor and interferon\u2014gamma upon mitogen stimulation. J Hepatol 1992;15:129\u2013135.","journal-title":"J Hepatol"},{"key":"BF02788754_CR28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4049\/jimmunol.146.1.89","volume":"146","author":"J Water Van de","year":"1991","unstructured":"Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, Gershwin ME: Evidence for the targeting by 2-oxodehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991;146:89\u201394.","journal-title":"J Immunol"},{"key":"BF02788754_CR29","first-page":"995","volume":"21","author":"DE Jones","year":"1995","unstructured":"Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG: T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995;21: 995\u20131002.","journal-title":"Hepatology"},{"key":"BF02788754_CR30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0168-8278(95)80105-7","volume":"22","author":"T Miyamoto","year":"1995","unstructured":"Miyamoto T, Maeda T, Onishi S, Yamamoto Y: T-cell autoreactivity against a 28 kD biliary protein (B1-p28) in primary biliary cirrhosis. J Hepatol 1995;22:423\u2013430.","journal-title":"J Hepatol"},{"key":"BF02788754_CR31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.22.2.136","volume":"22","author":"LE Munoz","year":"1981","unstructured":"Munoz LE, Thomas HC, Scheurer JP, Doniach D, Sherlock S: Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut 1981;22:136\u2013140.","journal-title":"Gut"},{"key":"BF02788754_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8278(86)80015-0","volume":"2","author":"PA Berg","year":"1986","unstructured":"Berg PA, Klein R, Lindenborn-Ponitus J: Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol 1986;2:123\u2013128.","journal-title":"J Hepatol"},{"key":"BF02788754_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.1840080128","volume":"8","author":"ME Gershwin","year":"1988","unstructured":"Gershwin ME, Coppel RI, Mackay IR: Primary biliary cirrhosis and mitochondrial autoantigens-insights from molecular biology. Hepatology 1988;8:147\u2013151.","journal-title":"Hepatology"},{"key":"BF02788754_CR34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08916938909014705","volume":"4","author":"N Zurgil","year":"1989","unstructured":"Zurgil N, Konikof F, Bakimer R, Slor H, Shoenfeld Y: Detection of antimitochondrial antibodies:characterization by enzyme immunoassay and immunoblotting. Autoimmunity 1989;4:289\u2013297.","journal-title":"Autoimmunity"},{"key":"BF02788754_CR35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.1840080146","volume":"8","author":"PA Berg","year":"1988","unstructured":"Berg PA, Klein R: Molecular determination of primary biliary cirrhosis specific M2 antigen. Hepatology 1988;8:200\u2013201.","journal-title":"Hepatology"},{"key":"BF02788754_CR36","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A, Coppel R: Identification and specificity of cDNA encoding the 70 Kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525\u20133531.","journal-title":"J Immunol"},{"key":"BF02788754_CR37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","volume":"1","author":"SJ Yeaman","year":"1988","unstructured":"Yeaman SJ, Danner DJ, Muriner DJ, Gussey SPM, James OFW, Bassendine MF: PBC, identification of two major M2 mitochondrial autoantigens. Lancet 1988; 1:1067\u20131069.","journal-title":"Lancet"},{"key":"BF02788754_CR38","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","volume":"85","author":"SPM Fussey","year":"1988","unstructured":"Fussey SPM, Guest JR, James OFW, Bassendine MF, Yeaman SJ: Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654\u20138658.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02788754_CR39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840100202","volume":"10","author":"CD Surh","year":"1989","unstructured":"Surh CD, Roche TE, Danner DJ, Ansari A, Coppel RL, Prindiville T, Dickson ER, Gershwin ME: Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross reactive epitopes on protein x and dihydrolipoamide acyltransferase of pyruvate dehydrogenase complex. Hepatology 1989;10:127\u2013133.","journal-title":"Hepatology"},{"key":"BF02788754_CR40","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4049\/jimmunol.144.5.1671","volume":"144","author":"DR Fregeau","year":"1990","unstructured":"Fregeau DR, Roche TE, Davis PA, Coppel R, Gershwin ME: Inhibition of pyruvate-dehydrogenase activity by autoantibodies specific for E1a, a non-lipoic acid containing mitochondrial enzyme. J Immunol 1990;144:1671\u20131676.","journal-title":"J Immunol"},{"key":"BF02788754_CR41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.1780310310","volume":"31","author":"DR Fregeau","year":"1988","unstructured":"Fregeau DR, Leung PS, Coppel RI, McNeilage LJ, Medsger TA Jr, Gershwin ME: Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum 1988;31:386\u2013392.","journal-title":"Arthritis Rheum"},{"key":"BF02788754_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0923-2494(96)82045-1","volume":"147","author":"H Amital","year":"1996","unstructured":"Amital H, Swissa M, Bar-Dayan Y, Buskila D, Shoenfeld Y: New therapeutic avenues in autoimmunity. Res Immunol 1996; 147:361\u2013376.","journal-title":"Res Immunol"},{"key":"BF02788754_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.510240128","volume":"24","author":"T Pasha","year":"1996","unstructured":"Pasha T, Heathcote J, Cauchdudek K: Cost effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1996, 24:169 (abstract).","journal-title":"Hepatology"},{"key":"BF02788754_CR44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","volume":"16","author":"M Yoshikawa","year":"1992","unstructured":"Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, Ishizaka S: Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992;16:358\u2013364.","journal-title":"Hepatology"},{"key":"BF02788754_CR45","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.156.4.1601","volume":"156","author":"H Tanaka","year":"1996","unstructured":"Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, Makino I: Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 1996;156:1601\u20131608.","journal-title":"J Immunol"},{"key":"BF02788754_CR46","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","volume":"330","author":"RE Poupon","year":"1994","unstructured":"Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group: Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342\u20131347.","journal-title":"N Engl J Med"},{"key":"BF02788754_CR47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","volume":"106","author":"KD Lindor","year":"1994","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Martaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, et al.: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284\u20131290.","journal-title":"Gastroenterology"},{"key":"BF02788754_CR48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","volume":"19","author":"EJ Heathcote","year":"1994","unstructured":"Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ, et al.: The Canadian multicenter doubleblind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994;19:1149\u20131156.","journal-title":"Hepatology"},{"key":"BF02788754_CR49","first-page":"759","volume":"22","author":"B Combes","year":"1995","unstructured":"Combes B, Carithers RL Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, Munoz SJ, Rubin R, Garcia-Tsao G, et al.: A randomized double blind placebo controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995;22: 759\u2013766.","journal-title":"Hepatology"},{"issue":"Suppl Al","key":"BF02788754_CR50","first-page":"163","volume":"110","author":"R Carithers","year":"1996","unstructured":"Carithers R, Luketic V, Peters M: Extended follow up of patients in the US multi-center trial of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1996; 110:Suppl Al 163 (abstract).","journal-title":"Gastroenterology"},{"key":"BF02788754_CR51","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"RE Poupon","year":"1997","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997:113:884\u2013890.","journal-title":"Gastroenterology"},{"key":"BF02788754_CR52","unstructured":"Beuers U, Kullak-Ublick G, Paumgartner G: Mechanism of action of UDCA in cholestatic syndromes, in Alvaro D, Benedetti A, Strazzabosco M (eds.): Vanishing Bile Duct Syndrome\u2014Pathophysiology and Treatment. Dordrecht Kluwer Academic Publishers, 1997, pp 230\u2013239."}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02788754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02788754\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02788754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T18:44:16Z","timestamp":1737744256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02788754"}},"subtitle":["Is (and How Much of) the pathology preventible?"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["BF02788754"],"URL":"https:\/\/doi.org\/10.1007\/bf02788754","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}